Park Dong Won, Choi Jiin, Chung Sung Jun, Park Tai Sun, Lee Hyun, Moon Ji-Yong, Kim Sang-Heon, Kim Tae-Hyung, Yoon Ho Joo, Sohn Jang Won
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
Biostatistical Consulting and Research Lab, Medical Research Collaborating Center, Hanyang University, Seoul, Korea.
Transl Cancer Res. 2020 Apr;9(4):2627-2637. doi: 10.21037/tcr.2020.03.02.
This study determined whether the survival of lung cancer (LC) patients with rheumatoid arthritis (RA) is differed by histological subtype.
This observational, retrospective study compared the LC survival rate of 34 RA patients with that of 132 age- and sex-matched patients without RA who received medical care from 2011 to 2016. Survival curves were generated using the Kaplan-Meier method. Cox proportional hazards regression analyses were used to estimate hazard ratios and determine risk factors predicting mortality according to histological subtype, including small cell lung cancer (SCLC), and non-small cell lung cancer (NSCLC).
The predominant histological subtype was adenocarcinoma in both groups, however, a larger proportion of SCLC patients was noted in patients with both LC and RA, compared to those with LC but without RA (26.5% 12.9%, respectively; P=0.0317). LC patients with RA had a significantly lower body mass index (P=0.0488), and a higher proportion of interstitial lung disease (P<0.0001), compared to patients without RA. There was no statistical difference in the distribution of smoking status, stage, or comorbidity index between groups. Overall survival did not differ between LC patients with and without RA. Mortality was significantly worse for RA patients with SCLC than those with NSCLC (P=0.0404), and RA was associated with a 3.26-fold increase in mortality for SCLC patients with versus without RA (P=0.0350; 95% confidence interval: 1.05-9.56). However, RA was not a risk factor for mortality in NSCLC and, even in histological subtypes including lung adenocarcinoma and squamous cell carcinoma.
RA was not associated with a lower overall survival rate for LC patients, irrespective of histological subtype. Because the effects of RA on LC mortality might differ between SCLC and NSCLC patients, future studies should recognize that the histological subtype may affect the outcome.
本研究旨在确定患有类风湿性关节炎(RA)的肺癌(LC)患者的生存率是否因组织学亚型而异。
这项观察性回顾性研究比较了2011年至2016年期间接受医疗护理的34例RA患者与132例年龄和性别匹配的非RA患者的LC生存率。使用Kaplan-Meier方法生成生存曲线。Cox比例风险回归分析用于估计风险比,并根据组织学亚型确定预测死亡率的风险因素,包括小细胞肺癌(SCLC)和非小细胞肺癌(NSCLC)。
两组中主要的组织学亚型均为腺癌,然而,与患有LC但无RA的患者相比,患有LC和RA的患者中SCLC患者的比例更高(分别为26.5%和12.9%;P=0.0317)。与无RA的患者相比,患有RA的LC患者体重指数显著更低(P=0.0488),间质性肺病的比例更高(P<0.0001)。两组之间吸烟状况、分期或合并症指数的分布无统计学差异。有RA和无RA的LC患者的总生存率无差异。患有SCLC的RA患者的死亡率明显高于患有NSCLC的患者(P=0.0404),并且RA与患有和未患有RA的SCLC患者的死亡率增加3.26倍相关(P=0.